Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayakrishna Ambati

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Neuron|July 17, 2012
Mechanisms of age-related macular degenerationJayakrishna Ambati, Benjamin J Fowler
Developments in Ophthalmology|October 27, 2015
Complement Activation and Inhibition in Retinal DiseasesMark E Kleinman, Jayakrishna Ambati
JACC. Basic to Translational Science|January 11, 2021
NLRP3 Inflammasome Inhibition: A Potential Therapeutic Strategy to Attenuate Postinfarction Adverse Cardiac RemodelingSiddharth Narendran, Felipe Pereira, Jayakrishna Ambati
JAMA Ophthalmology|July 11, 2024
Facilitating Drug Repurposing-Using Databases for Drug Discovery in AMDJoseph Magagnoli, S Scott Sutton, Jayakrishna Ambati
JAMA Ophthalmology|May 9, 2024
Acetylcholinesterase Inhibitors, AMD, and Alzheimer Disease-ReplyJoseph Magagnoli, S Scott Sutton, Jayakrishna Ambati
Nature Reviews. Immunology|May 25, 2013
Immunology of age-related macular degenerationJayakrishna Ambati, John P Atkinson, Bradley D Gelfand
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 18, 2010
The multifactorial nature of retinal vascular diseaseMark E Kleinman, Judit Z Baffi, Jayakrishna Ambati
Journal of Molecular Graphics & Modelling|June 15, 2007
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC proteinVasu Chandrasekaran, Jayakrishna Ambati, Balamurali K Ambati, et al.
Annals of the New York Academy of Sciences|October 22, 2010
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptorsHelena Pavlakovic, Jürgen Becker, Romulo Albuquerque, et al.
Medcomm - Future Medicine|April 22, 2024
Survey of commercial antibodies targeting Y chromosome-encoded genesBradley D Gelfand, Dionne A Argyle, Joseph J Olivieri, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Neuron|July 17, 2012
Mechanisms of age-related macular degenerationJayakrishna Ambati, Benjamin J Fowler
Developments in Ophthalmology|October 27, 2015
Complement Activation and Inhibition in Retinal DiseasesMark E Kleinman, Jayakrishna Ambati
JACC. Basic to Translational Science|January 11, 2021
NLRP3 Inflammasome Inhibition: A Potential Therapeutic Strategy to Attenuate Postinfarction Adverse Cardiac RemodelingSiddharth Narendran, Felipe Pereira, Jayakrishna Ambati
JAMA Ophthalmology|July 11, 2024
Facilitating Drug Repurposing-Using Databases for Drug Discovery in AMDJoseph Magagnoli, S Scott Sutton, Jayakrishna Ambati
JAMA Ophthalmology|May 9, 2024
Acetylcholinesterase Inhibitors, AMD, and Alzheimer Disease-ReplyJoseph Magagnoli, S Scott Sutton, Jayakrishna Ambati
Nature Reviews. Immunology|May 25, 2013
Immunology of age-related macular degenerationJayakrishna Ambati, John P Atkinson, Bradley D Gelfand
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 18, 2010
The multifactorial nature of retinal vascular diseaseMark E Kleinman, Judit Z Baffi, Jayakrishna Ambati
Journal of Molecular Graphics & Modelling|June 15, 2007
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC proteinVasu Chandrasekaran, Jayakrishna Ambati, Balamurali K Ambati, et al.
Annals of the New York Academy of Sciences|October 22, 2010
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptorsHelena Pavlakovic, Jürgen Becker, Romulo Albuquerque, et al.
Medcomm - Future Medicine|April 22, 2024
Survey of commercial antibodies targeting Y chromosome-encoded genesBradley D Gelfand, Dionne A Argyle, Joseph J Olivieri, et al.
Pageof 12